Agios Pharmaceuticals, Inc. · NASDAQ:AGIO

Dapice Joshua J. reported a 9.90% stake in Agios Pharmaceuticals, Inc. (Schedule 13G/A)

Event Dec 31, 2024 · Filed Feb 4, 2025

Dapice Joshua J. reported a 9.90% stake in Agios Pharmaceuticals, Inc., 5,674,466 shares, as a passive investor on Dec 31, 2024. Filed Feb 4, 2025 (Schedule 13G/A).

Stake
9.90%
Shares
5,674,466
Intent
Passive
What changed
Stake changed
Filed together
30 holders

The filing in full

HolderStakeShares
Farallon Capital Partners, L.P.0.70%422,479
Farallon Capital Institutional Partners, L.P.0.80%480,410
Farallon Capital Institutional Partners II, L.P.0.20%141,724
Farallon Capital Institutional Partners III, L.P.0.10%52,905
Four Crossings Institutional Partners V, L.P.0.20%97,097
Farallon Capital Offshore Investors II, L.P.1.50%866,239
Farallon Capital (AM) Investors, L.P.0.10%62,523
Farallon Capital F5 Master I, L.P.0.40%222,073
Farallon Healthcare Partners Master, L.P.5.80%3,329,016
Farallon Partners, L.L.C.9.60%5,452,393
Farallon Institutional (GP) V, L.L.C.0.20%97,097
Farallon F5 (GP), L.L.C.0.40%222,073
Farallon Healthcare Partners (GP), L.L.C.5.80%3,329,016
Dapice Joshua J.9.90%5,674,466
Dreyfuss, Philip D.9.90%5,674,466
Dunn Hannah E.9.90%5,674,466
Fried, Richard B9.90%5,674,466
Gehani, Varun N.9.90%5,674,466
Giauque, Nicolas9.90%5,674,466
Kim, David T.9.90%5,674,466
Linn, Michael G.9.90%5,674,466
Luo Patrick (Cheng)9.90%5,674,466
Patel, Rajiv A.9.90%5,674,466
Roberts, Jr., Thomas G.9.90%5,674,466
Saito Edric C.9.90%5,674,466
Seybold, William9.90%5,674,466
Short Daniel S.9.90%5,674,466
Spokes, Andrew J. M.9.90%5,674,466
Warren, John R.9.90%5,674,466
Wehrly, Mark C.9.90%5,674,466

Source

View original at SEC

Related